ATLANTA -- Diabetes was associated with an increased risk for developing a type of liver cancer called hepatocellular carcinoma, and this association was highest for Latinos, followed by Hawaiians, African-Americans, and Japanese-Americans, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.
"People with diabetes have a two- to threefold higher risk for hepatocellular carcinoma compared with those without diabetes," said V. Wendy Setiawan, Ph.D., assistant professor in the Department of Preventive Medicine at Keck School of Medicine of the University of Southern California. "We also found that the interethnic differences in the prevalence of diabetes were consistent with the pattern of hepatocellular carcinoma incidence observed across ethnicities: Ethnic groups with a high prevalence of diabetes also have high hepatocellular carcinoma rates, and those with a lower prevalence of diabetes have lower hepatocellular carcinoma rates."
The number of new cases of hepatocellular carcinoma in the United States tripled in the past three decades, with Latinos and African-Americans experiencing the largest increase in incidence. Prior research has suggested that diabetes may be a risk factor for hepatocellular carcinoma, and its increasing incidence may be contributing to the rising rate of hepatocellular carcinoma.
"People with diabetes should be aware that their condition is associated with a higher risk of developing hepatocellular carcinoma," Setiawan said. "Maintaining a healthy weight, managing their diabetes, preventing and treating hepatitis infection, and limiting alcohol and tobacco use should be in their priority to-do list."
In addition, Setiawan said that public health efforts encouraging obesity/diabetes prevention and effective diabetes management should be directed at high-risk populations.
Setiawan and colleagues examined if the association between diabetes and hepatocellular carcinoma differed by race/ethnic group. They analyzed data from more than 150,000 people enrolled in the Multiethnic Cohort Study between 1993 and 1996. During the study follow-up period of about 15 years, 506 cases of hepatocellular carcinoma were reported: 59 cases in non-Hispanic whites, 81 in African-Americans, 33 in Hawaiians, 158 in Japanese-Americans, and 175 in Latinos.
Compared with non-Hispanic whites, Latinos had 2.77 times the risk for being diagnosed with hepatocellular carcinoma, the highest risk identified. Native Hawaiians had 2.48 times the risk; African-Americans, 2.16; and Japanese-Americans, 2.07.
The prevalence of diabetes was consistent with that of hepatocellular carcinoma. Sixteen percent of Hawaiians, 15 percent of Latinos and African-Americans, 10 percent of Japanese-Americans, and 6 percent of non-Hispanic whites had diabetes. Compared with those without diabetes, Latinos with diabetes had 3.3-fold higher risk for hepatocellular carcinoma; Hawaiians, 2.33-fold higher risk; Japanese-Americans, 2.02-fold higher risk; African-Americans, 2.02-fold higher risk; and non-Hispanic whites had 2.17-fold higher risk.
Hepatocellular carcinoma was attributed to diabetes in 26 percent of cases in Latinos, 20 percent of Hawaiians, 13 percent of African-Americans, 12 percent of Japanese-Americans, and 6 percent of non-Hispanic whites, the researchers estimated. According to Setiawan, eliminating diabetes could potentially reduce hepatocellular carcinoma incidence in all racial/ethnic groups, with the largest potential reduction possible in Latinos.
This study was funded by the National Cancer Institute. Setiawan has declared no conflicts of interest.
To interview Wendy Setiawan, contact Leslie Ridgeway at email@example.com or 323-442-2823. For other inquiries, contact Jeremy Moore at firstname.lastname@example.org or 215-446-7109.
Follow the AACR on Twitter: @AACR
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit http://www.AACR.org.
Abstract Number: PR09
Presenter: V. Wendy Setiawan, Ph.D.
Title: Diabetes and racial/ethnic differences in hepatocellular carcinoma risk: the Multiethnic Cohort
Authors: Veronica Wendy Setiawan1, Brenda Hernandez2, Daniel Stram1, Lynne Wilkens2, Loic Le Marchand2, Brian E. Henderson1. 1University of Southern California, Los Angeles, CA, 2University of Hawaii Cancer Center, Honolulu, HI.
Background: Hepatocellular carcinoma (HCC) incidence has tripled in the US over the past three decades. Diabetes has been suggested as an emerging risk factor for HCC and its increasing prevalence may contribute to the rising incidence of HCC. Data from prospective studies on the relationship between diabetes and HCC in multiethnic populations are scarce. Here we examined whether the association between diabetes and HCC risk differs across racial/ethnic groups, and whether the association is modified by known HCC risk factors.
Methods: We conducted a prospective analysis of 169,479 African-American, Native Hawaiian, Japanese-American, Latino and white men and women who were recruited into the Multiethnic Cohort (MEC) Study between 1993 and 1996. During a median follow-up period of 15.7 years, a total of 506 incident HCC cases (59 whites, 81 African Americans, 33 Hawaiians, 158 Japanese, and 175 Latinos) were identified among the cohort participants. Data on known and suspected risk factors were obtained from baseline questionnaire. Serologic testing for hepatitis B (HBV) and C (HCV) infection was performed on a subset of cohort subjects (233 cases and 460 non cases). Cox proportional hazards models stratified by sex and adjusted for age, alcohol drinking, body mass index (BMI in kg/m2) and cigarette smoking were used to calculate relative risks (RRs) and 95% confidence intervals (CIs) for HCC associated with diabetes for each ethnic group. The population attributable risk percent associated with diabetes was also calculated for each ethnic group.
Results: Incidence rates of HCC markedly differed across race/ethnic groups; the age-adjusted RRs for HCC (vs. whites) were 2.77 (95% CI: 2.03, 3.78) for Latinos, 2.48 (95% CI: 1.59, 3.86) for Native Hawaiians, 2.16 (95% CI: 1.52, 3.07) for African Americans, and 2.07 (95% CI: 1.51, 2.38) for Japanese. The age- and sex-adjusted prevalence of diabetes at baseline also varied across ethnic groups: 16% in Hawaiians, 15% in Latinos, 15% in African Americans, 10% in Japanese, and 6% whites (P<0.0001). Diabetes was strongly associated with HCC risk in all ethnic groups (P-heterogeneity=0.40); the RR was 3.33 (95% CI: 2.39, 4.63) in Latinos, 2.54 (95% CI: 1.13, 5.70) in Hawaiians, 2.33 (95% CI: 1.60, 3.40) in Japanese, 2.02 (95% CI: 1.17, 3.49) in African Americans, and 2.17 (95% CI: 0.95, 4.93) in whites. BMI, smoking status, and alcohol intake did not modify the diabetes-HCC association (P interaction ≥ 0.19). Within a subset of cohort participants with available HBV and HCV serologic data, diabetes was not associated with infection status (P ≥ 0.07). We estimated that 26% of HCC cases in Latinos, 20% in Hawaiians, 13% in African Americans, 12% in Japanese, and 6% in whites were attributed to diabetes.
Conclusions: In the MEC, Latinos were at the highest risk of developing HCC, followed by Native Hawaiians, African Americans, Japanese and whites. We showed that diabetes is a strong risk factor for HCC in all ethnic groups and that the inter-ethnic differences in the prevalence of diabetes was consistent with the pattern of HCC incidence observed across ethnicities. Finally, we showed that eliminating diabetes could potentially reduce HCC incidence in all racial/ethnic groups, with the largest potential for reduction in Latinos.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.